Aquestive patents expiration
1. Sympazan patents expiration
SYMPAZAN's oppositions filed in EPO
SYMPAZAN Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8765167 | AQUESTIVE | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
Feb, 2024
(4 months from now) | |
| US8603514 | AQUESTIVE | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
Apr, 2024
(6 months from now) | |
Drugs and Companies using CLOBAZAM ingredient
Market Authorisation Date: 01 November, 2018
Treatment: NA
Dosage: FILM;ORAL
More Information on Dosage
SYMPAZAN family patents
2. Zuplenz patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8580830 | AQUESTIVE | Non-mucoadhesive film dosage forms |
Nov, 2029
(6 years from now) | |
| US9095577 | AQUESTIVE | Stabilized amine-containing actives in oral film compositions |
Jul, 2030
(6 years from now) | |
Drugs and Companies using ONDANSETRON ingredient
Market Authorisation Date: 02 July, 2010
Treatment: NA
Dosage: FILM;ORAL
More Information on Dosage
ZUPLENZ family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic